Reaction between ellagic acid and an ultimate carcinogen

Journal of Chemical Information and Modeling

Volumn 45, Issue 6, 2005, Pages 1564-1570

  Huetz, Philippe ^a   Mavaddat, Nasim ^b   Mavri, Janez ^a,c  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NATIONAL INSTITUTE OF CHEMISTRY   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION ENERGY; CARBOXYLIC ACIDS; DERIVATIVES; POLYCYCLIC AROMATIC HYDROCARBONS; PROBABILITY DENSITY FUNCTION; TUMORS;

DENSITY FUNCTIONAL THEORY; DIPOLE METHODS; ELLAGIC ACID; REACTIVITY;

CARCINOGENS;

ANTINEOPLASTIC AGENT; BENZO[A]PYRENE 7,8 DIHYDRODIOL 9,10 OXIDE; CARCINOGEN; ELLAGIC ACID;

ALGORITHM; ARTICLE; CHEMISTRY; COMPUTER SIMULATION; MEDICINAL PLANT; PH; PHYSICAL CHEMISTRY;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; ALGORITHMS; ANTICARCINOGENIC AGENTS; CARCINOGENS; CHEMISTRY, PHYSICAL; COMPUTER SIMULATION; ELLAGIC ACID; HYDROGEN-ION CONCENTRATION; PLANTS, MEDICINAL;

EID: 28944455241     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci050163c     Document Type: Conference Paper

References (74)

1. Miller, A. B.; Bartsch, H. Hair dye use and bladder cancer. Int. J. Cancer 2001, 94, 901-902.
2. Czene, K.; Tiikkaja, S.; Hemminki, K. Cancer risks in hairdressers: assessment of carcinogenicity of hair dyes and gels. Int. J. Cancer 2003, 105, 108-112.
3. Hecht, S. S. Tobacco smoke carcinogens and lung cancer. J. Natl. Cancer Inst. 1999, 91, 1194-1210. Review.
4. Guyton, K. Z.; Kensler, T. W. Prevention of liver cancer. Curr. Oncol. Rep. 2002, 4, 464-470. Review.
5. Farmer, P. B.; Singh, R.; Kaur, B.; Sram, R. J.; Binkova, B.; Kalina, I.; Popov, T. A.; Garte, S.; Taioli, E.; Gabelova, A.; Cebulska-Wasilewska, A. Molecular epidemiology studies of carcinogenic environmental pollutants. Effects of polycyclic aromatic hydrocarbons (PAHs) in environmental pollution on exogenous and oxidative DNA damage. Mutat. Res. 2003, 544, 397-402. Review.
6. Baudouin, C.; Charveron, M.; Tarroux, R.; Gall, Y. Environmental pollutants and skin cancer. Cell Biol. Toxicol. 2002, 18, 341-348. Review.
7. Barone, P. M. V. B.; Camilo, A., Jr; Galvão, D. S. Theoretical approach to identify carcinogenic activity of polycyclic aromatic hydrocarbons. Phys. Rev. Lett. 1996, 77, 1186-1189.
8. Brookes, P.; Lawley, P. D. Evidence for the binding of polynuclear aromatic hydrocarbons to the nucleic acids of mouse skin: relation between carcinogenic power of hydrocarbons and their binding to deoxyribonucleic acid. Nature 1964, 202, 781-784.
9. Jerina, D. M.; Chadha, A.; Cheh, A. M.; Schudak, M. E.; Wood, A. W.; Sayer, J. M. In Biological Reactive Intermediates, IV: Molecular and Cellular Effects and their Impact on Human Health; Witmer, C. M., Snyder, R., Jollow, D. J., Kalf, G. F., Kocsis, J. J., Sipes, L. G., Eds.; Plenum: New York, 1991; pp 533-553.
10. Thakker, D. R.; Yagi, H.; Levin, W.; Wood, A. W.; Conney, A. H.; Jerina, D. M. In Bioactivation of Foreign Compounds; Ander, M. W., Ed.; Academy: New York, 1985; pp 177-242.
11. Conney, A. H.; Chang, R. L.; Jerina, D. M.; Wei, S. J. Studies on the metabolism of benzo[a]pyrene and dose-dependent differences in the mutagenic profile of its ultimate carcinogenic metabolite. Drug Metab. Rev. 1994, 26, 125-163. Review.
12. Cooper, C. S.; Pal, K.; Hewer, A.; Grover, P. L.; Sims, P. The metabolism and activation of polycyclic aromatic hydrocarbons in epithelial cell aggregates and fibroblasts prepared from rat mammary tissue. Carcinogenesis 1982, 3, 203-210.
13. Shimada, T.; Gillam, E. M.; Oda, Y.; Tsumura, F.; Sutter, T. R.; Guengerich, F. P.; Inoue, K. Metabolism of benzo[a]pyrene to trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene by recombinant human cytochrome P450 1B1 and purified liver epoxide hydrolase. Chem. Res. Toxicol. 1999, 12, 623-629.
14. Slaga, T. J.; Bracken, W. J.; Gleason, G.; Levin, W.; Yagi, H.; Jerina, D. M.; Conney, A. H. Marked differences in the skin tumor-initiating activities of the optical enantiomers of the diastereomeric benzo(a)-pyrene 7,8-diol-9,10-epoxides. Cancer Res. 1979, 39, 67-71.
15. Buening, M. K.; Wislocki, P. G.; Levin, W.; Yagi, H.; Thakker, D. R.; Akagi, H.; Koreeda, M.; Jerina, D. M.; Conney, A. H. Tumorigenicity of the optical enantiomers of the diastereomeric benzo[a]-pyrene 7,8-diol-9,10-epoxides in newborn mice: exceptional activity of (+)-7β, 8α-dihydroxy- 9α,10α-epoxy-7,8,9,10-tetrahydrobenzo[a]-pyrene. Proc. Natl. Acad. Sci. U.S.A. 1978, 75, 5358-5361.
16. Huetz, P.; Poux, V. Chemical Reactivity of Benzo[a]pyrene Diol Epoxide Stereoisomers toward Guanine and Adenine: a Linear Free Energy Relationships-based Comparison. Submitted for publication.
17. Jerina, D. M.; Cheh, A. M.; Chadha, A.; Yagi, J.; Sayer, J. M. In Microsomes and Drug Oxidations, Proceedings of the 7th International TAYLOR Symposium; Miners, J. O., Birkett, D. J., Drew, R., May, B. K., McManus, M. E., Eds.; Taylor and Francis: London, 1988; pp 354-362.
18. Szeliga, J.; Dipple, A. DNA adduct formation by polycyclic aromatic hydrocarbon dihydrodiol epoxides. Chem. Res. Toxicol. 1998, 11, 1-11.
19. Sayer, J. M.; Chadha, A.; Agarwal, S. K.; Yeh, H. J. C.; Yagi, H.; Jerina, D. M. Covalent nucleoside adducts of a benzo[a]pyrene 7,8-diol 9,10-epoxides: structural reinvestigation and characterization of a novel adenosine adduct on the ribose moiety. J. Org. Chem. 1991, 56, 20-29.
20. Alexandrov, K.; Cascorbi, I.; Rojas, M.; Bouvier, G.; Kriek, E.; Bartsch, H. CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formation. Carcinogenesis 2002, 23, 1969-1977. Review.
21. Soussi, T. P53 Antibodies in the sera of patients with various types of cancer: a review. Cancer Res. 2000, 60, 1777-1788.
22. Wiencke, J. K. DNA adduct burden and tobacco Carcinogenesis. Oncogene 2002, 21, 7376-7391.
23. Godschalk, R. W.; Schooten, F. J.; Bartsch, H. A critical evaluation of DNA adducts as biological markers for human exposure to polycyclic aromatic compounds. J. Biochem. Mol. Biol. 2003, 36, 1-11.
24. Pommier, Y.; Kohlhagen, G.; Pourquier, P.; Sayer, J. M.; Kroth, H.; Jerina, D. M. Benzo[a]pyrene diol epoxide adducts in DNA are potent suppressors of a normal topoisomerase I cleavage site and powerful inducers of other topoisomerase I cleavages. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 2040-2045.
25. Liang, Z.; Lippman, S. M.; Kawabe, A.; Shimada, Y.; Xu, X. C. Identification of benzo(a)pyrene diol epoxide-binding DNA fragments using DNA immunoprecipitation technique. Cancer Res. 2003, 63, 1470-1474.
26. Sayer, J. M.; Yagi, H.; Wood, A. W.; Conney, A. H.; Jerina, D. M. Extremely facile reaction between the ultimate carcinogen benzo[a]-pyrene-7,8- diol 9,10-epoxide and ellagic acid. J. Am. Chem. Soc. 1982, 104, 5562-5564.
27. Wood, A. W.; Huang, M. T.; Chang, R. L.; Newmark, H. L.; Lehr, R. E.; Yagi, H.; Sayer, J. M.; Jerina, D. M.; Conney, A. H. Inhibition of the mutagenicity of bay-region diol epoxides of polycyclic aromatic hydrocarbons by naturally occurring plant phenols: exceptional activity of ellagic acid. Proc. Natl. Acad. Sci. U.S.A. 1982, 79, 5513-5517.
28. Kresty, L. A.; Morse, M. A.; Morgan, C.; Carlton, P. S.; Lu, J.; Gupta, A.; Blackwood, M.; Stoner, G. D. Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized black raspberries. Cancer Res. 2001, 61, 6112-6119.
29. Xue, H.; Aziz, R. M.; Sun, N.; Cassady, J. M.; Kamendulis, L. M.; Xu, Y.; Stoner, G. D.; Klaunig, J. E. Inhibition of cellular transformation by berry extracts. Carcinogenesis 2001, 22, 351-356.
30. Teel, R. W.; Dixit, R.; Stoner, G. D. The effect of ellagic acid on the uptake, persistence, metabolism and DNA-binding of benzo[a]pyrene in cultured explants of strain A/J mouse lung. Carcinogenesis 1985, 6, 391-395.
31. Gerhauser, C.; Klimo, K.; Heiss, E.; Neumann, I.; Gamal-Eldeen, A.; Knauft, J.; Liu, G. Y.; Sitthimonchai, S.; Frank, N. Mechanism-based in vitro screening of potential cancer chemopreventive agents. Mutat. Res. 2003, 523-524, 163-172.
32. Perchellet, J. P.; Gali, H. U.; Perchellet, E. M.; Klish, D. S.; Armbrust, A. D. Antitumor-promoting activities of tannic acid, ellagic acid, and several gallic acid derivatives in mouse skin. Basic Life Sci. 1992, 59, 783-801.
33. Boukharta, M.; Jalbert, G.; Castonguay, A. Biodistribution of ellagic acid and dose-related inhibition of lung tumorigenesis in A/J mice. Nutr. Cancer 1992, 18, 181-189.
34. Siglin, J. C.; Barch, D. H.; Stoner, G. D. Effects of dietary phenethyl isothiocyanate, ellagic acid, sulindac and calcium on the induction and progression of N-nitrosomethylbenzylamine-induced esophageal Carcinogenesis in rats. Carcinogenesis 1995, 16, 1101-1106.
35. Castonguay, A. Pulmonary Carcinogenesis and its prevention by dietary polyphenolic compounds. Ann. N. Y. Acad. Sci. 1993, 686, 177-185.
36. Stoner, G. D.; Mukhtar, H. Polyphenols as cancer chemopreventive agents. J. Cell. Biochem. Suppl. 1995, 22, 169-180. Review.
37. Smith, W. A.; Gupta, R. C. Determining efficacy of cancer chemopreventive agents using a cell-free system concomitant with DNA adduction. Mutat. Res. 1999, 425, 143-152.
38. Smith, W. A.; Freeman, J. W.; Gupta, R. C. Effect of chemopreventive agents on DNA adduction induced by the potent mammary carcinogen dibenzo[a,l]pyrene in the human breast cells MCF-7. Mutat. Res. 2001, 480-481, 97-108.
39. Smart, R. C.; Huang, M. T.; Chang, R. L.; Sayer, J. M.; Jerina, D. M.; Wood, A. W.; Conney, A. H. Effect of ellagic acid and 3-O-decylellagic acid on the formation of benzo[a]pyrene-derived DNA adducts in vivo and on the tumorigenicity of 3-methylcholanthrene in mice. Carcinogenesis 1986, 7, 1669-1675.
40. Huang, C.; Huang, Y.; Li, J.; Hu, W.; Aziz, R.; Tang, M. S.; Sun, N.; Cassady, J.; Stoner, G. D. Inhibition of benzo(a)pyrene diol-epoxide-induced transactivation of activated protein 1 and nuclear factor kappaB by black raspberry extracts. Cancer Res. 2002, 62, 6857-6863.
41. Dixit, R.; Teel, R. W.; Daniel, F. B.; Stoner, G. D. Inhibition of benzo-(a)pyrene and benzo(a)pyrene-trans-7,8-diol metabolism and DNA binding in mouse lung explants by ellagic acid. Cancer Res. 1985, 45, 2951-2956.
42. Barch, D. H.; Rundhaugen, L. M.; Stoner, G. D.; Pillay, N. S.; Rosche, W. A. Structure-function relationships of the dietary anticarcinogen ellagic acid. Carcinogenesis 1996, 17, 265-269.
43. Chang, R. L.; Huang, M. T.; Wood, A. W.; Wong, C. Q.; Newmark, H. L.; Yagi, H.; Sayer, J. M.; Jerina, D. M.; Conney, A. H. Effect of ellagic acid and hydroxylated flavonoids on the tumorigenicity of benzo[a]pyrene and (±)-7βJ,8α-dihydroxy-9α,10α-epoxy-7,8,9, 10-tetrahydrobenzo[a]pyrene on mouse skin and in the newborn mouse. Carcinogenesis 1985, 6, 1127-1133.
44. Szaefer, H.; Jodynis-Liebert, J.; Cichocki, M.; Matuszewska, A.; Baer-Dubowska, W. Effect of naturally occurring plant phenolics on the induction of drug metabolizing enzymes by o-toluidine. Toxicology 2003, 186, 67-77.
45. Barch, D. H.; Fox, C. C. Selective inhibition of methylbenzylnitro- samine-induced formation of esophageal O6-methylguanine by dietary ellagic acid in rats. Cancer Res. 1988, 48, 7088-7092.
46. Teel, R. W. Ellagic acid binding to DNA as a possible mechanism for its antimutagenic and anticarcinogenic action. Cancer Lett. 1986, 30, 329-336.
47. Barch, D. H.; Rundhaugen, L. M.; Pillay, N. S. Ellagic acid induces transcription of the rat glutathione S-transferase-Ya gene. Carcinogenesis 1995, 16, 665-668.
48. Festa, F.; Aglitti, T.; Duranti, G.; Ricordy, R.; Perticone, P.; Cozzi, R. Strong antioxidant activity of ellagic acid in mammalian cells in vitro revealed by the comet assay. Anticancer Res. 2001, 21, 3903-3908.
49. Narayanan, B. A.; Geoffroy, O.; Willingham, M. C.; Re, G. G.; Nixon, D. W. P53/p21(WAF1/CIP1) expression and its possible role in G1 arrest and apoptosis in ellagic acid treated cancer cells. Cancer Lett. 1999, 136, 215-221.
50. Garcia-Viloca, M.; Gao, J.; Karplus, M.; Truhlar, D. G. How enzymes work: analysis by modern rate theory and computer simulations. Science 2004, 303, 186-195.
51. Geacintov, N. E.; Hibshoosh, H.; Ibanez, V.; Benjamin, M. J.; Harvey, R. G. Mechanisms of reaction of benzo[a]pyrene-7,8-diol-9, 10-epoxide with DNA in aqueous solutions. Biophys. Chem. 1984, 20, 121-133.
52. Becke, A. D. Density-functional thermochemistry. III. The role of exact exchange. J. Chem. Phys. 1993, 98, 5648-5652.
53. Lee, C.; Yang, W.; Parr, R. G. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys. Rev. B 1988, 37, 785-789.
54. Garcia-Viloca, M.; Alhambra, C.; Truhlar, D. G.; Gao, J. Hydride transfer catalyzed by xylose isomerase: mechanism and quantum effects. J. Comput. Chem. 2003, 24, 177-190.
55. Tomasi, J.; Persico, M. Molecular interactions in solution: an overview of methods based on continuous distributions of the solvent. Chem. Rev. 1994, 94, 2027-2094.
56. Frediani, L.; Cammi, R.; Pomelli, C. S.; Tomasi, J.; Ruud, K. New developments in the symmetry-adapted algorithm of the Polarizable Continuum Model. J. Comput. Chem. 2004, 25, 375-385.
57. Florian, J.; Warshel, A. Langevin dipoles model for ab initio calculations of chemical processes in solution: parametrization and application to hydration free energies of neutral and ionic solutes and conformational analysis in aqueous solution. J. Phys. Chem. B 1997, 101, 5583-5595.
58. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Zakrzewski, V. G.; Montgomery, J. A., Jr.; Stratmann, R. E.; Burant, J. C.; Dapprich, S.; Millam, J. M.; Daniels, A. D.; Kudin, K. N.; Strain, M. C.; Farkas, O.; Tomasi, J.; Barone, V.; Cossi, M.; Cammi, R.; Mennucci, B.; Pomelli, C.; Adamo, C.; Clifford, S.; Ochterski, J.; Petersson, G. A.; Ayala, P. Y.; Cui, Q.; Morokuma, K.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Cioslowski, J.; Ortiz, J. V.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Gomperts, R.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Gonzalez, C.; Challacombe, M.; Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Andres, J. L.; Gonzalez, C.; Head-Gordon, M.; Replogle, E. S.; Pople, J. A. Gaussian 98, Revision A.5; Gaussian, Inc.: Pittsburgh, PA, 1998.
59. Florián, J.; Warshel, A. ChemSol, Version 2.1; University of Southern California: Los Angeles, 1999.
60. Mavri, J. Irreversible inhibition of the HIV-1 protease: a theoretical study. Int. J. Quantum Chem. 1998, 69, 753-759.
61. Lin, S. S.; Hung, C. F.; Tyan, Y. S.; Yang, C. C.; Hsia, T. C.; Yang, M. D.; Chung, J. G. Ellagic acid inhibits arylamine N-acetyltransferase activity and DNA adduct formation in human bladder tumor cell lines (T24 and TSGH 8301). Urol. Res. 2001, 29, 371-376.
62. Whitley, A. C.; Stoner, G. D.; Darby, M. V.; Walle, T. Intestinal epithelial cell accumulation of the cancer preventive polyphenol ellagic acid - extensive binding to protein and DNA. Biochem. Pharmacol. 2003, 66, 907-915.
63. Teel, R. W.; Martin, R. M. Disposition of the plant phenol ellagic acid in the mouse following oral administration by gavage. Xenobiotica 1988, 18, 397-405.
64. Smart, R. C.; Huang, M. T.; Chang, R. L.; Sayer, J. M.; Jerina, D. M.; Conney, A. H. Disposition of the naturally occurring antimutagenic plant phenol, ellagic acid, and its synthetic derivatives, 3-O-decylellagic acid and 3, 3′-di-O-methylellagic acid in mice. Carcinogenesis 1986, 7, 1663-1667.
65. Huang, X.; Colgate, K. C.; Kolbanovskiy, A.; Amin, S.; Geacintov, N. E. Conformational changes of a benzo[a]pyrene diol epoxide-N(2)-dG adduct induced by a 5′-flanking 5-methyl-substituted cytosine in a (Me)CG double-stranded oligonucleotide sequence context. Chem. Res. Toxicol. 2002, 15, 438-444.
66. Deng, J. Z.; Marshall, R.; Jones, S. H.; Johnson, R. K.; Hecht, S. M. DNA-damaging agents from Crypteronia paniculata. J. Nat. Prod. 2002, 65, 1930-1932.
67. Keck, A. S.; Finley, J. W. Cruciferous vegetables: cancer protective mechanisms of glucosinolate hydrolysis products and selenium. Integr. Cancer Ther. 2004, 3, 5-12. Review.
68. Park, E. J.; Pezzuto, J. M. Botanicals in cancer chemoprevention. Cancer Metastasis Rev. 2002, 21, 231-255. Review.
69. Rushmore, T. H.; Kong, A. N. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr. Drug Metab. 2002, 3, 481-490. Review.
70. Kazi, A.; Smith, D. M.; Daniel, K.; Zhong, S.; Gupta, P.; Bosley, M. E.; Dou, Q. P. Potential molecular targets of tea polyphenols in human tumor cells: significance in cancer prevention. In Vivo 2002, 16, 397-403. Review.
71. Nessa, F.; Ismail, Z.; Mohamed, N.; Haris, M. R. H. M. Phytochemical investigation on Blumea balsamifera DC. J. Trop. Med. Plants 2001, 2, 17-22.
72. Seneci, P. Solid-phase Synthesis and Combinatorial Technologies; Wiley: Ed., 2000.
73. Combinatorial Chemistry and Technology - Principals, Methods and Applications; Miertus, S., Giogio, F., Eds.; Marcel Dekker: 1999.
74. Jorgensen, W. L. The many roles of computation in drug discovery. Science 2004, 303, 1813-1818.